Genomma Lab Internacional, S.A.B. de C.V. (FRA:GEKA)

Market Cap	713.98M -8.5%
Revenue (ttm)	835.54M -6.0%
Net Income	83.56M +53.1%
EPS	0.06 +14.6%
Shares Out	n/a
PE Ratio	11.17
Forward PE	7.41
Dividend	0.04 (5.73%)
Ex-Dividend Date	Sep 29, 2026

Volume	1,500
Open	0.6800
Previous Close	0.6600
Day's Range	0.6800 - 0.6800
52-Week Range	0.5950 - 0.9500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 21, 2026

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 1,658
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GEKA

Financial Performance

In 2025, Genomma Lab Internacional's revenue was 17.54 billion, a decrease of -5.73% compared to the previous year's 18.61 billion. Earnings were 1.61 billion, an increase of 8.10%.

Financial numbers in MXN

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error